Similar articles

• The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope.

  Qingyou Z, Junbao D, Chaoshu T. Qingyou Z, et al. J Pediatr. 2006 Dec;149(6):777-80. doi: 10.1016/j.jpeds.2006.07.031. J Pediatr. 2006. PMID: 17137891 Clinical Trial.
• Midodrine for the Prevention of Vasovagal Syncope : A Randomized Clinical Trial.

  Sheldon R, Faris P, Tang A, Ayala-Paredes F, Guzman J, Marquez M, Morillo CA, Krahn AD, Kus T, Ritchie D, Safdar S, Maxey C, Raj SR; POST 4 investigators. Sheldon R, et al. Ann Intern Med. 2021 Oct;174(10):1349-1356. doi: 10.7326/M20-5415. Epub 2021 Aug 3. Ann Intern Med. 2021. PMID: 34339231 Clinical Trial.
• Rationale for the prevention of syncope trial IV: assessment of midodrine.

  Raj SR, Faris PD, McRae M, Sheldon RS. Raj SR, et al. Clin Auton Res. 2012 Dec;22(6):275-80. doi: 10.1007/s10286-012-0167-5. Epub 2012 May 19. Clin Auton Res. 2012. PMID: 22610268 Free PMC article. Clinical Trial.
• Pharmacologic approaches to therapy for vasovagal syncope.

  Calkins H. Calkins H. Am J Cardiol. 1999 Oct 21;84(8A):20Q-25Q. doi: 10.1016/s0002-9149(99)00626-8. Am J Cardiol. 1999. PMID: 10568557 Review.
• A comparison of postspace-flight orthostatic intolerance to vasovagal syncope and autonomic failure and the potential use of the alpha agonist midodrine for these conditions.

  Piwinski SE, Jankovic J, McElligott MA. Piwinski SE, et al. J Clin Pharmacol. 1994 May;34(5):466-71. doi: 10.1002/j.1552-4604.1994.tb04988.x. J Clin Pharmacol. 1994. PMID: 7522240 Review.